Study on the Preparation and Biomedical Properties of Multi-Scale Polymeric Nanomaterials by 宋存峰
  
学校编码：10384                               分类号      密级     
学    号：20720110153492                                  UDC     
 
 
 
 
 
博  士  学  位  论  文 
多种尺度高分子纳米材料的制备及其 
生物医学性能研究 
Study on the Preparation and Biomedical Properties of 
Multi-Scale Polymeric Nanomaterials 
 
宋存峰 
 
指导教师姓名： 戴 李 宗   教 授 
专 业 名 称 ： 高分子化学与物理 
论文提交日期： 2015年 10月 
论文答辩时间： 2015年 12月 
学位授予日期： 2015年   月 
 
2015年   月 
 
厦
门
大
学
博
硕
士
论
文
摘
要
库
厦
门
大
学
博
硕
士
论
文
摘
要
库
厦
门
大
学
博
硕
士
论
文
摘
要
库
 I 
摘要 
生物高分子材料的发展关系到现代医学的进步，与人的身体健康和生命质量
息息相关。随着高分子制备技术的重大突破，纳米尺度的高分子材料以其独特的
生物医学性能，逐渐成为生物材料领域的研究热点。本论文采用多种高分子纳米
材料的制备技术，包括链内交联法、自组装法、无皂乳液聚合法和表面接枝法，
设计合成了多种尺度的高分子纳米材料（从超细纳米粒子到二维纳米层），并系
统地评价了它们的生物医学性能。研究工作在高分子纳米材料的设计与合成、拓
展其在生物医学领域的应用等方面具有积极的意义。主要研究内容如下： 
1. 单链聚合物 P(HEMA-co-PDSEMA)超细纳米粒子的制备及药物控释性能
研究 
使用可简易制得的单体甲基丙烯酸吡啶二硫乙酯（PDSEMA），合成了无规
共聚物 P(HEMA-co-PDSEMA)。单分子链通过二硫键的自交联作用，在温和条件
下形成粒径可控（7至 11 nm）、可被动靶向的单链聚合物纳米粒子（SCNPs）。
考察了交联密度、聚合物分子量和初始浓度对形成 SCNPs 的影响。体外药物释
放实验显示：由于二硫键的还原响应性，SCNPs 在类似细胞内环境的还原条件
下，响应性地释放总载药量的 83.2%。同时，SCNPs的体外释药行为符合一级释
放动力学模型（0.8929≤ R2 ≤0.9904）。综上所述，所制备的 SCNPs适用于被动靶
向及还原响应性靶向的双重定位给药系统。 
2. P(MMA-co-HEMA)-g-PNIPAAm胶束的制备及药物控释性能研究 
设计了一种新型大分子链转移剂用于“grafting from”法合成双亲性接枝共
聚物。合成的双亲性接枝共聚物[P(MMA-co-HEMA)-g-PNIPAAm]自组装形成粒
径约为 90 nm 的胶束。该尺度的纳米胶束易进入细胞，可用于增溶疏水性药物
DOX并减少其毒副作用。体外实验研究了 P(MMA-co-HEMA)-g-PNIPAAm胶束
的温度响应性释放药物性能。胶束具有可逆的温度响应性，当温度为 37 oC 时，
胶束的累积释药量为 52.4%。随温度升高，胶束的释药速率加快。胶束的体外释
药行为符合一级释放动力学模型（0.9632≤ R2 ≤0.9963），温度的升高（大于 LCST）
提高了药物扩散的速率。同时，体外细胞毒性和细胞摄取实验表明，胶束具有良
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好的生物相容性，且容易被细胞跨膜摄取。而通过负载 DOX后，胶束对癌细胞
的生长有较强的抑制作用。 
3. PSA/Ag-NPs复合球的制备及抗菌性能研究 
采用无皂乳液聚合技术合成的聚（苯乙烯-co-丙烯酸）（PSA）微球为基体，
制备粒径可控（200至 500 nm）的 PSA/Ag-NPs复合球，作为抗菌填料。PSA微
球具有良好的单分散性，表面羧基能有效的将银粒子固定，是用于制备均一性银
/聚合物抗菌填料的理想基体。通过抑菌圈、最小抑菌浓度、最小灭菌浓度和灭
菌动力测试，研究了填料的抗菌性能。实验证实了 PSA/Ag-NPs复合球对革兰氏
阳性菌 S. aureus和革兰氏阴性菌 E. coli均有较强的抑制作用。 
4. 接枝 QPMAMP 二维纳米层的 AAO-SiO2复合膜的制备及蛋白分离性能
研究 
在 AAO-SiO2 膜表面化学接枝季铵化的聚（N-甲基-3-吡啶甲基丙烯酰胺）
（QPMAMP）分子刷，形成聚阳离子电解质的二维纳米层结构，作为新型离子
交换膜材料。相比离子官能团，QPMAMP分子刷不但提供了更多的蛋白质结合
位点，并且，通过改变自身构象可以有效的从分离组分中“捕获”目标蛋白。系
统地研究了接枝 QPMAMP 的复合膜对白蛋白（OVA）的吸附性能，结果显示，
膜的静态吸附容积为 98.5 mg/g膜，动态吸附容积为 65.3 mg/g膜。对比商业化
的传统离子交换膜，复合膜对蛋白质的吸附容积有了显著的提高。接枝 QPMAMP
的复合膜对蛋白质的吸附符合 Freundlich等温吸附，R2=0.9952。另外，QPMAMP
接枝的复合膜作为强阴离子型离子交换膜，表现了高度的选择性和易于洗脱性能。 
 
关键词：链内交联；自组装；无皂乳液聚合；表面接枝；药物控释；抗菌活性；
蛋白分离 
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Abstract 
The development of biopolymer materials is closely correlated to the progress of 
modern medicine, which directly influences the health and quality of life of human 
beings. Along with the breakthrough of polymer preparation technology, the 
nanoscale polymer materials gradually become a hot spot of the field of biomaterials 
because of their unique biomedical properties. In the present thesis, through the 
combination of various preparation technologies, such as the intrachain crosslinking, 
self-assembly, soap-free emulsion polymerization, and surface grafting method, 
polymer nanomaterials with different dimension were prepared (from ultrafine 
particles to the 2D-nanolayers), and their biomedical properties were systematically 
evaluated. The present research is significant on the design, the preparation and the 
biomedical properties improvement of polymeric nanomaterials. The main 
researching contents are as follows: 
1. Preparation of single polymer P(HEMA-co-PDSEMA) ultra-fine 
nanoparticles and study on controlled drug release property  
Using monomers PDSEMA which can be prepared easily, random copolymer 
P(HEMA-co-PDSEMA) was synthesized. Through disulfide-based intrachain 
crosslinking, passive targeting SCNPs with tunable size from 7 to 11 nm can be 
formed under mild conditions. The influence of the crosslinking density, the 
molecular weight and the initial concentration of the polymer upon the formation of 
SCNPs was also studied as well. Due to the crosslinked disulfide bond has redox 
responsiveness, in vitro release experiments showed that SCNPs released 83.2% of 
the total drug loadings only under the reduction level in the cell. Meanwhile, the drug 
in vitro release behaviors of SCNPs fit with the frist-order kinetic model (0.8929≤ R2 
≤0.9904). Thus, the prepared SCNPs have potential to be applied to both the passive 
targeting and the redox-responsive targeting dual positioning drug delivery system. 
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2. Preparationof P(MMA-co-HEMA)-g-PNIPAAm micelles and research on 
controlled drug release property  
A new type of macro-RAFT agent was designed to synthesize graft copolymer 
through "grafting from". The amphiphilic graft copolymer 
[P(MMA-co-HEMA)-g-PNIPAAm] underwent self-assembly to form micelles with a 
diameter around 90 nm. The micelles can encapsulate hydrophobic DOX to reduce its 
toxicity. The thermo-responsive drug release property of 
P(MMA-co-HEMA)-g-PNIPAAm micelle was studied by in vitro release experiment. 
The results showed that the micelles have reversible thermo-responsiveness. When 
the temperature reached 37 oC, the cumulative release amount was 52.4%. Along with 
the increase of temperature, the drug release was accelerated. The drug in vitro release 
behaviors of these micelles fit with the first-order models (0.9632≤ R2 ≤0.9963). 
When the temperature is up to LCST, the diffusion rate will accelerated. At the same 
time, cellular cytotoxicity and cellular uptake results showed that micelles has good 
biological compatibility and can be taken easily. Meanwhile, DOX-loaded micelles 
can inhibit the growth of cancer cells. 
3. Preparation of PSA/Ag-NPs nanocomposites and study on antibacterial 
activity  
The synthesized PSA nanospheres via soap-free emulsion polymerization, were 
used as matrixes to prepare PSA/Ag-NPs nanocomposites with tunable size from 200 
nm to 500 nm as antibacterial filler. PSA nanospheres have a good monodispersity 
and can effectively fix silver particles, thus, they are the idea candidates for the 
preparation of uniform silver/polymer antibacterial filler. Their effects on antibacterial 
activity including inhibition zone, MIC, MBC and bacteriaicidal kinetics were 
evaluated. During these tests, PSA/Ag-NPs antibacterial nanocomposites showed 
excellent antibacterial activity against both gram-positive S. aureus and 
gram-negative E. coli. 
4. Fabrication of QPMAMP-grafted AAO-SiO2 composite membrane and 
research on protein separation property  
QPMAMP brushes were grafted from the surface of AAO-SiO2 membrane to 
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form cationic polyelectrolyte nanolayer for the preparation of a new type of 
ion-exchange membrane. The polyelectrolyte brush possesses more binding sites and 
higher flexibility. A series of experiments were carried out to investigate the OVA 
adsorption performance of QPMAMP-grafted composite membrane. Results showed 
that the adsorption capacities reached 95.8 mg/g membranes (static) and 65.3 mg/g 
membranes (dynamic). Comparing with the commercial traditional ion-exchange 
membrane, the protein adsorption capacity has been improved significantly. The 
equilibrium adsorption was well-described by Freundlich isothermal (R2=0.9952). 
Furthermore, the fabricated QPMAMP-grafted composite membrane as strong 
anionic-exchange membrane, exhibited high selectivity and easy elution performance. 
 
Keywords: intrachain crosslinking; self-assembly; soap-free emulsion polymerization; 
surface grafting; controlled drug release; antibacterial activity; protein separation 
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